Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.
Journal: Endocrine-related cancer
Published: November 07, 2018
CHL1 expression differentiates Hürthle cell carcinoma from benign Hürthle cell nodules.
Journal: Journal of surgical oncology
Published: May 30, 2018
STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.
Journal: Annals of surgical oncology
Published: September 25, 2017
Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target.
Journal: Endocrine pathology
Published: August 28, 2017
Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma.
Journal: Annals of surgical oncology
Published: March 22, 2017
Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
Journal: Thyroid : official journal of the American Thyroid Association
Published: March 08, 2016
Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma.
Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 16, 2016
Characteristics of contralateral carcinomas in patients with differentiated thyroid cancer larger than 1 cm.
Journal: Langenbeck's archives of surgery
Published: November 20, 2015
Minimal impact of calcimimetics on the management of hyperparathyroidism in chronic dialysis.
Journal: Surgery
Published: February 28, 2015
Cost disparity between health care systems--it's not the surgeons: A cost analysis of thyroid cancer care between the United States and France.
Journal: Surgery
Published: February 18, 2015
Last Updated: 09/26/2026